Skip to content
RollCall logo

Video

The new way prosecutors are using an old act

And how it's affecting drug CEOs

[jwp-video n="1"]
By Nathan Ouellette and Jinitzail Hernández
Posted December 3, 2019 at 2:15pm

As the effects of the opioid crisis are felt across the country, federal prosecutors are taking action and prosecuting CEOs of pharmaceutical companies. The Controlled Substance Act is one of their most novel weapons. 

Watch as CQ Roll Call’s senior multimedia producer Jinitzail Hernández explains how.  

[jwp-video n=”1″]

Recent Stories

Ukrainian President Volodymyr Zelenskyy is greeted, from left, by Sen. Richard Blumenthal, D-Conn., Sen. Jim Risch, R-Idaho, and Sen. Roger Wicker, R-Miss., as he arrives to meet with senators in the Capitol on Tuesday.

Senate weighs next steps on Russia-Iran sanctions

Sen. Jim Banks, R-Ind., arrives for the Senate Republicans’ lunch meeting in the Capitol on July 21.

Lawmakers want better data on AI’s workforce impacts

Idaho Democrat David Roth is dropping out of the Senate race. (Screenshot/C-SPAN)

Idaho Democrat is latest Senate nominee to drop out in boost to independent rival

A sign referencing high gas prices and Rep. Mike Lawler, R-N.Y., is seen at an event hosted by VoteVets calling for an end to the Iran war outside the Capitol on May 20. (Tom Williams/CQ Roll Call)

‘People just don’t see it’: Trump’s midterms messaging sounds a lot like Biden

Acting Attorney General Todd Blanche leaves a meeting in the Hart Senate Office Building on Wednesday.

Senate panel postpones Blanche attorney general vote

Capitol Ink | Hard times at the DNC